Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPA-LN
NCT07700940Phase 4Recruiting
- Sponsor
- Ahmed Yehia Ismail
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in lupus nephritis (LN), sponsored by Ahmed Yehia Ismail. Started Jan 2024; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT07700940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07700940.